
### [NCIT:C41247](http://purl.obolibrary.org/obo/NCIT_C41247)
**Label:** Pancreatic Mucinous-Cystic Neoplasm

**Subclasses:** [NCIT:C41246](http://purl.obolibrary.org/obo/NCIT_C41246) (Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma), [NCIT:C95488](http://purl.obolibrary.org/obo/NCIT_C95488) (Non-Invasive Pancreatic Mucinous-Cystic Neoplasm), [NCIT:C95483](http://purl.obolibrary.org/obo/NCIT_C95483) (Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia), [NCIT:C95493](http://purl.obolibrary.org/obo/NCIT_C95493) (Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia), 

**Class expressions from DL-Learner:**

- Thing 53.45%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 52.78%
- [NCIT:C34333](http://purl.obolibrary.org/obo/NCIT_C34333) (Abdominal Mass) 52.78%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C36118](http://purl.obolibrary.org/obo/NCIT_C36118) (In Situ Lesion))) 52.78%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 38.13%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 38.13%


